Orchard Therapeutics Reached An Agreement With The Beneluxa Initiative On Pharmaceutical Policy (Beneluxa) Enabling Reimbursed Access To Libmeldy= (Atidarsagene Autotemcel) Approved For The Treatment Of Early-onset Metachromatic Leukodystrophy (MLD)
Orchard Therapeutics与Beneluxa药物政策倡议（Beneluxa）达成协议，允许报销获得批准用于治疗早发性变色性白质营养不良（MLD）的Libmeldy=（Atidarsagene Autotemcel）